文献速递腹部MR

原发性肝癌中LR-M标准的诊断效能及LI-RADS影像特征谱

Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

回顾性纳入有危险因素的行手术治疗的肝内胆管癌16例和混合型肝细胞-胆管癌33例,并与大小匹配的肝细胞癌49例对照,依据LI-RADS v2018评估术前MRI。LR-M标准诊断胆管癌或混合型肝细胞-胆管癌的敏感度67.3%、特异度89.8%;出现超过两个LR-M特征时特异度达95.9%。

要点

  • LR-M标准诊断胆管癌或混合型肝细胞-胆管癌敏感度67.3%、特异度89.8%。
  • 出现超过两个LR-M特征时诊断胆管癌或混合型肝细胞-胆管癌特异度95.9%。
  • 非肝细胞癌组中67.3%归为LR-M、28.6%归为LR-5,肝细胞癌组中10.2%归为LR-M、77.6%归为LR-5。

核心结论

  • LR-M标准对胆管癌和混合型肝细胞-胆管癌的诊断效能可接受,敏感度中等、特异度高。
  • 原发性肝癌的影像表现应理解为一种谱系。

研究设计与样本

  • 回顾性研究,2013至2018年单家三级医院经手术诊断胆管癌67例和混合型肝细胞-胆管癌43例,纳入有危险因素者16例胆管癌和33例混合型肝细胞-胆管癌。
  • 另选49例大小匹配的肝细胞癌作为对照组,两名独立阅片者依据LI-RADS第2018版评估术前MRI并赋予LI-RADS分类。
  • 对无危险因素者51例胆管癌和10例混合型肝细胞-胆管癌的肿瘤影像表现进行亚组分析。

诊断标准与关键数值

  • 非肝细胞癌组中33例归为LR-M、14例归为LR-5,分别占67.3%和28.6%;肝细胞癌组中5例归为LR-M、38例归为LR-5,分别占10.2%和77.6%。
  • LR-M标准诊断胆管癌或混合型肝细胞-胆管癌的敏感度67.3%、特异度89.8%。
  • 出现超过两个LR-M特征时提示胆管癌或混合型肝细胞-胆管癌,特异度95.9%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the diagnostic performance of LR-M criteria for differentiating hepatocellular carcinoma, intrahepatic mass-forming cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma and to compare the imaging features of each type.

METHODS: In this retrospective study, 110 patients were surgically diagnosed with cholangiocarcinoma (n = 67) and combined hepatocellular-cholangiocarcinoma (n = 43) at a single tertiary hospital between 2013 and 2018. Among them, those with risk factors were enrolled (16 cholangiocarcinomas and 33 combined hepatocellular-cholangiocarcinomas). Forty-nine other patients with size-matched hepatocellular carcinoma were selected as a control group. Two independent readers evaluated the imaging findings of the preoperative MRIs based on LI-RADS version 2018 and assigned an LI-RADS category. The diagnostic performance of the LR-M criteria for diagnosing cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma was evaluated, and the imaging features were compared. The imaging findings of the tumors in patients without risk factors (51 cholangiocarcinomas and 10 combined hepatocellular-cholangiocarcinomas) were evaluated for subgroup analysis.

RESULTS: In the non-hepatocellular carcinoma group, 33 patients were categorized into LR-M and 14 patients into LR-5 (67.3% and 28.6%, respectively), while 5 patients with hepatocellular carcinoma were categorized into LR-M and 38 patients into LR-5 (10.2% and 77.6%, respectively). Sensitivity and specificity of the LR-M criteria were 67.3% and 89.8%, respectively. When more than two LR-M features were present, cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma were suggested with a specificity of 95.9%.

CONCLUSION: The diagnostic performance of the LR-M criteria is acceptable with moderate sensitivity and high specificity for both cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Imaging findings of primary hepatic carcinomas should be understood as a spectrum.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kim SS, Lee S, Choi JY, et al. Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas. Abdom Radiol (NY). 2020. PMID: 32377757. doi:10.1007/s00261-020-02562-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。